Reply to the Letter to the Editor: Why Did the “Five-Year Incidence of Progression to Osteoarthritis and Total Joint Arthroplasty in Patients Prescribed Glucagon-Like Peptide 1 Receptor Agonists” Differ From the Previous Randomized Controlled Study?

IF 3.4 2区医学 Q1 ORTHOPEDICS

Journal of Arthroplasty Pub Date : 2024-11-08 DOI:10.1016/j.arth.2024.08.036

Monish S. Lavu MHM, Joshua R. Porto MS, Christian J. Hecht II, David C. Kaelber MD, PhD, MPH, Peter K. Sculco MD, Nathanael D. Heckmann MD, Atul F. Kamath MD, MBA

引用次数: 0

查看原文本刊更多论文

回复致编辑的信：为什么 "胰高血糖素样肽 1 受体激动剂处方患者骨关节炎和全关节关节置换术五年进展发生率 "与之前的随机对照研究有所不同？

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Journal of Arthroplasty 医学-整形外科

CiteScore

7.00

自引率

20.00%

发文量

734

审稿时长

48 days

期刊介绍： The Journal of Arthroplasty brings together the clinical and scientific foundations for joint replacement. This peer-reviewed journal publishes original research and manuscripts of the highest quality from all areas relating to joint replacement or the treatment of its complications, including those dealing with clinical series and experience, prosthetic design, biomechanics, biomaterials, metallurgy, biologic response to arthroplasty materials in vivo and in vitro.